Comabella M - Search Results

1

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.

Hegen H, Millonig A, Bertolotto A, Comabella M, Giovanonni G, Guger M, Hoelzl M, Khalil M, Killestein J, Lindberg R, Malucchi S, Mehling M, Montalban X, Polman CH, Rudzki D, Schautzer F, Sellebjerg F, Sørensen PS, Deisenhammer F. Hegen H, et al. Among authors: comabella m. Mult Scler. 2014 Apr;20(5):577-87. doi: 10.1177/1352458513503597. Epub 2013 Sep 5. Mult Scler. 2014. PMID: 24009164

2

[Headache in an epidemic of multiple sclerosis: should other causes be excluded?].

Comabella M, Montalbán X, Tintoré M, Codina A. Comabella M, et al. Med Clin (Barc). 1996 Mar 16;106(10):397-8. Med Clin (Barc). 1996. PMID: 8637286 Spanish. No abstract available.

3

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.

Río J, Nos C, Tintoré M, Borrás C, Galán I, Comabella M, Montalban X. Río J, et al. Among authors: comabella m. Ann Neurol. 2002 Oct;52(4):400-6. doi: 10.1002/ana.10290. Ann Neurol. 2002. PMID: 12325067 Clinical Trial.

4

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

Tintoré M, Rovira A, Río J, Nos C, Grivé E, Sastre-Garriga J, Pericot I, Sánchez E, Comabella M, Montalban X. Tintoré M, et al. Among authors: comabella m. Neurology. 2003 Jan 14;60(1):27-30. doi: 10.1212/wnl.60.1.27. Neurology. 2003. PMID: 12525713

5

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

Sastre-Garriga J, Tintoré M, Rovira A, Grivé E, Pericot I, Comabella M, Thompson AJ, Montalban X. Sastre-Garriga J, et al. Among authors: comabella m. Mult Scler. 2003 Feb;9(1):39-43. doi: 10.1191/1352458503ms847oa. Mult Scler. 2003. PMID: 12617267 Clinical Trial.

6

Decreased MMP-9 production in primary progressive multiple sclerosis patients.

Sastre-Garriga J, Comabella M, Brieva L, Rovira A, Tintoré M, Montalban X. Sastre-Garriga J, et al. Among authors: comabella m. Mult Scler. 2004 Aug;10(4):376-80. doi: 10.1191/1352458504ms1058oa. Mult Scler. 2004. PMID: 15327032

7

Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.

Comabella M, Altet L, Peris F, Villoslada P, Sánchez A, Montalban X. Comabella M, et al. Mult Scler. 2004 Dec;10(6):618-20. doi: 10.1191/1352458504ms1097oa. Mult Scler. 2004. PMID: 15584484

8

Plasma osteopontin levels in multiple sclerosis.

Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, Blas Navarro J, Río J, Montalban X. Comabella M, et al. J Neuroimmunol. 2005 Jan;158(1-2):231-9. doi: 10.1016/j.jneuroim.2004.09.004. J Neuroimmunol. 2005. PMID: 15589058 Clinical Trial.

9

Is optic neuritis more benign than other first attacks in multiple sclerosis?

Tintoré M, Rovira A, Rio J, Nos C, Grivé E, Téllez N, Pelayo R, Comabella M, Montalban X. Tintoré M, et al. Among authors: comabella m. Ann Neurol. 2005 Feb;57(2):210-5. doi: 10.1002/ana.20363. Ann Neurol. 2005. PMID: 15668965

10

Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients.

Río J, Nos C, Tintoré M, Téllez N, Galán I, Pelayo R, Comabella M, Montalban X. Río J, et al. Among authors: comabella m. Ann Neurol. 2006 Feb;59(2):344-52. doi: 10.1002/ana.20740. Ann Neurol. 2006. PMID: 16437558 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page